In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
Top Cited Papers
Open Access
- 21 December 2015
- journal article
- research article
- Published by Springer Nature in Nature Nanotechnology
- Vol. 11 (3) , 295-303
Abstract
Nanotechnology has tremendous potential to contribute to cancer immunotherapy. The ‘in situ vaccination’ immunotherapy strategy directly manipulates identified tumours to overcome local tumour-mediated immunosuppression and subsequently stimulates systemic antitumour immunity to treat metastases. We show that inhalation of self-assembling virus-like nanoparticles from cowpea mosaic virus (CPMV) reduces established B16F10 lung melanoma and simultaneously generates potent systemic antitumour immunity against poorly immunogenic B16F10 in the skin. Full efficacy required Il-12, Ifn-γ, adaptive immunity and neutrophils. Inhaled CPMV nanoparticles were rapidly taken up by and activated neutrophils in the tumour microenvironment as an important part of the antitumour immune response. CPMV also exhibited clear treatment efficacy and systemic antitumour immunity in ovarian, colon, and breast tumour models in multiple anatomic locations. CPMV nanoparticles are stable, nontoxic, modifiable with drugs and antigens, and their nanomanufacture is highly scalable. These properties, combined with their inherent immunogenicity and demonstrated efficacy against a poorly immunogenic tumour, make CPMV an attractive and novel immunotherapy against metastatic cancer.Keywords
This publication has 47 references indexed in Scilit:
- Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic CarcinomaCancer Immunology Research, 2015
- Virus-Like Particles as Antigenic Nanomaterials for Inducing Protective Immune Responses in The LungNanomedicine, 2014
- Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple AdjuvantsCancer Research, 2014
- Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T CellsCancer Immunology Research, 2013
- Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer MicroenvironmentCancer Research, 2013
- Cowpea Mosaic Virus Nanoparticles Target Surface Vimentin on Cancer CellsNanomedicine, 2011
- Evidence for a cross-talk between human neutrophils and Th17 cellsBlood, 2010
- Efficient generation of cowpea mosaicvirus empty virus-like particles by the proteolytic processing of precursors in insect cells and plantsVirology, 2009
- Inducible Bronchus-Associated Lymphoid Tissue Elicited by a Protein Cage Nanoparticle Enhances Protection in Mice against Diverse Respiratory VirusesPLOS ONE, 2009
- Inhibition of tumor growth by elimination of granulocytes.Journal of Experimental Medicine, 1995